Gene | CVST Group, N (%) N = 70 | Control group, N (%) N = 82 | P Value |
Factor-V-Leiden (H)a | 8 | 1 | 0.012 |
Factor-V-Leiden HR2(H) | 24 | 15 | 0.019 |
Factor-V-Leiden HR2(M)b | 2 | 0 | 0.019 |
Prothrombin II (G20210A)(H) | 7 | 0 | 0.004 |
MTHFR (667C/T)(H) | 20 | 41 | 0.007 |
MTHFR (667C/T)(M) | 8 | 2 | 0.007 |
MTHFR (1298A/C)(H) | 32 | 48 | 0.036 |
MTHFR (1298A/C)(M) | 15 | 6 | 0.036 |
Plasminogen activator inhibitor (PAI)(H) | 36 | 48 | 0.602 |
Plasminogen activator inhibitor (PAI)(M) | 15 | 13 | 0.602 |
Angiotensin-converting enzyme (ACE)(H) | 40 | 44 | 0.808 |
Angiotensin-converting enzyme (ACE)(M) | 18 | 25 | 0.808 |
Beta-fibrinogen (FGB)(H) | 31 | 35 | 0.953 |
Beta-fibrinogen (FGB)(M) | 3 | 3 | 0.953 |
Factor VIII(H) | 26 | 33 | 0.110 |
Factor VIII(M) | 1 | 7 | 0.110 |
Factor XIII(H) | 13 | 18 | 0.558 |
Factor XIII(M) | 0 | 1 | 0.558 |
Tissue Plasminogen Activator (tPA)(H) | 37 | 22 | 0.000 |
Tissue Plasminogen Activator (tPA)(M) | 6 | 29 | 0.000 |
Glycoprotein1a(H) | 36 | 35 | 0.109 |
Glycoprotein 1a(M) | 6 | 17 | 0.109 |